Glanbia plc
GL9
Classifica tra le azioni
#3164
Operating globally as a prominent nutrition company, Glanbia plc specializes in... Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
Prezzo delle azioni
$23.09
Capitalizzazione di mercato
$5.58B
Variazione (1 giorno)
0.29%
Variazione (1 anno)
33.62%
Paese
IE
Scambia Glanbia plc (GL9)
Categoria
Consumer Defensive
Ricavi di Glanbia plc (GL9)
Ricavi nel Oct 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Glanbia plc, i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Glanbia plc da 2001 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2025 | $4.11B | 3.30% |
| 2024 | $3.98B | -26.72% |
| 2023 | $5.43B | -10.36% |
| 2022 | $6.05B | 26.82% |
| 2021 | $4.77B | 2.50% |
| 2020 | $4.66B | 7.07% |
| 2019 | $4.35B | 19.35% |
| 2018 | $3.64B | 27.20% |
| 2017 | $2.86B | 21.98% |
| 2016 | $2.35B | -22.05% |
| 2015 | $3.01B | -1.92% |
| 2014 | $3.07B | -6.24% |
| 2013 | $3.28B | 12.28% |
| 2012 | $2.92B | 16.60% |
| 2011 | $2.50B | -13.63% |
| 2010 | $2.90B | 10.38% |
| 2009 | $2.62B | -15.63% |
| 2008 | $3.11B | -33.85% |
| 2007 | $4.70B | 92.83% |
| 2006 | $2.44B | 12.78% |
| 2005 | $2.16B | -30.26% |
| 2004 | $3.10B | 20.62% |
| 2003 | $2.57B | 5.72% |
| 2002 | $2.43B | 17.08% |
| 2001 | $2.08B | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $115.21B | - |
CH
|
|
| - | - |
FR
|
|
| - | - |
JP
|
|
| - | - |
BR
|
|
| $24.90B | - |
US
|
